I am on a trial of Imbruvica and Venetoclax and doing well so far. I am 17P deleted so I am looking at future options- if needed. Fortunately there are a lot of new emerging treatments. I am not an expert - though. Feel free to add on copy , edit and repost!
Below are some of the new CLL treatments I see:
1) MCL1 Inhibitors . It seems like it would work well with Venetoclax and Imbruvica possibly a triple combo. I don't know if this type of trial is coming.
Holly I am starting the ACP-196 trial you have listed here which consists of Acalabrutinib-Venetoclax and Obinutuzumab infusions. Three meds total but doing Acalabrutinib alone for roughly 30 days then adding the Obinutuzumab infusions along with Acalabrutinib for roughly 30 days and then adding Venetoclax to them on a total trial study of 14 months. The Dr said the dosage levels of Acalabrutinib had to be started low and increased over several weeks before reaching full dosing. It's my understanding that once full doze is achieved they add Obinutuzumab infusions and again they must want to let your body respond or not then based on the test results if your able you then receive the Venetoclax and this becomes the cocktail for the balance of the trial period of 14 months. Bringing three different attack applications to seek kill and disable the cells and pathways. This may not be a good analogy but it's my limited view.
Let's hope so I like you have been looking further afield as I too am 17p and on ibrutinib doing very well as it stands venitclax will be my next followed as you have said with new agents and third generation blockers. We still have the option of stem cell graft BMT as well
Emerging CLL treatments beyond Imbruvica ( BTK Inhibitor ) and Venetoclax ( BCL-2 Blocker) Note: I am not an expert .
Hello,
I am on a trial of Imbruvica and Venetoclax and doing well so far. I am 17P deleted so I am looking at future options- if needed. Fortunately there are a lot of new emerging treatments. I am not an expert - though. Feel free to add on copy , edit and repost!
Below are some of the new CLL treatments I see:
1) MCL1 Inhibitors . It seems like it would work well with Venetoclax and Imbruvica possibly a triple combo. I don't know if this type of trial is coming.
ncbi.nlm.nih.gov/pubmed/268...
AZD5991
cancer.gov/publications/dic...
ME401
2) MicroRNA155 inhibitor. MicroRNA 155 is found in high quantity in aggressive CLL
ncbi.nlm.nih.gov/pubmed/249...
clinicaltrials.gov/ct2/show...
MRG-106 by Miragen
miragen.com/clinical-trials/
3) CAR-T with CD19 as a target
clinicaltrials.gov/ct2/show...
4) CAR-T with ROR1 as a target
ncbi.nlm.nih.gov/pmc/articl...
5) CAR-NK
mdanderson.org/publications...
6) Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab , CC-122 is next generation Revlimid (lenalidomide)
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
I am new here and about to start venetoclax/rituximab treatment.
CLL Treatment concerns 
Starting CAR-T therapy for my relapsing CLL
